CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Chief Operating Officer acquired 26,316 shares (grant or award)
- 4 Option exercise Director acquired 23,952 shares (option exercise)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
Page 5 of 21 · 420 filings